WO1988005296A3 - Compositions regulatrices de lipides - Google Patents

Compositions regulatrices de lipides Download PDF

Info

Publication number
WO1988005296A3
WO1988005296A3 PCT/US1988/000257 US8800257W WO8805296A3 WO 1988005296 A3 WO1988005296 A3 WO 1988005296A3 US 8800257 W US8800257 W US 8800257W WO 8805296 A3 WO8805296 A3 WO 8805296A3
Authority
WO
WIPO (PCT)
Prior art keywords
lpid
regulating compositions
regulating
dimethylphenoxy
hmg
Prior art date
Application number
PCT/US1988/000257
Other languages
English (en)
Other versions
WO1988005296A2 (fr
Inventor
Mahdi B Fawzi
Roger S Newton
Bruce D Roth
Gerald J Yakatan
Original Assignee
Warner Lambert Co
Mahdi B Fawzi
Roger S Newton
Bruce D Roth
Gerald J Yakatan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co, Mahdi B Fawzi, Roger S Newton, Bruce D Roth, Gerald J Yakatan filed Critical Warner Lambert Co
Publication of WO1988005296A2 publication Critical patent/WO1988005296A2/fr
Publication of WO1988005296A3 publication Critical patent/WO1988005296A3/fr
Priority to KR1019880701175A priority Critical patent/KR890700343A/ko
Priority to DK536088A priority patent/DK536088D0/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Des compositions pharmacologiques monodose contenant de l'acide 5-(2,5-diméthylphénoxy)-2,2-diméthylpentanoïque et un inhibiteur de la HMG-CoA réductase peuvent être utilisées efficacement pour réguler les niveaux de lipides et de cholestérol dans le sang.
PCT/US1988/000257 1987-01-27 1988-01-26 Compositions regulatrices de lipides WO1988005296A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1019880701175A KR890700343A (ko) 1987-01-27 1988-09-27 지질 조절용 조성물
DK536088A DK536088D0 (da) 1987-01-27 1988-09-27 Lipidregulerende praeparater

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US706187A 1987-01-27 1987-01-27
US007,061 1987-01-27

Publications (2)

Publication Number Publication Date
WO1988005296A2 WO1988005296A2 (fr) 1988-07-28
WO1988005296A3 true WO1988005296A3 (fr) 1988-09-22

Family

ID=21723996

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1988/000257 WO1988005296A2 (fr) 1987-01-27 1988-01-26 Compositions regulatrices de lipides

Country Status (5)

Country Link
EP (1) EP0276807A3 (fr)
KR (1) KR890700343A (fr)
AU (1) AU1422388A (fr)
DK (1) DK536088D0 (fr)
WO (1) WO1988005296A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925676A (en) * 1989-02-02 1990-05-15 Warner-Lambert Company Extended release gemfibrozil composition
US4927639A (en) * 1989-02-02 1990-05-22 Warner-Lambert Company Modified release gemfibrozil composition
GR1002098B (en) * 1989-06-08 1995-12-28 Squibb & Sons Inc Pharmaceutical composition having good stability
CA2039763A1 (fr) * 1990-04-30 1991-10-31 Henry Y. Pan Combinaison de provastatine et d'un derive de l'acide fibrique, et mode de traitement de la dyslipidemie a l'aide de cette combinaison
EP0462067A1 (fr) * 1990-06-15 1991-12-18 Warner-Lambert Company Formulations de gemfibrozil
DE19858789A1 (de) 1998-12-18 2000-06-21 Bayer Ag Kombination von Cerivastatin und Fibraten
AR040588A1 (es) 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
WO2005046662A2 (fr) 2003-11-07 2005-05-26 Jj Pharma, Inc. Complexes pour une therapie combinatoire stimulant les hdl
GB0427491D0 (en) 2004-12-16 2005-01-19 Avecia Ltd Process and compounds

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3846541A (en) * 1970-10-15 1974-11-05 Pharmacia Ab Treatment of hypercholesteremia
EP0010299A1 (fr) * 1978-10-19 1980-04-30 Merck & Co. Inc. Composition pharmaceutique utilisable pour le traitement d'hypercholestérémie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3674836A (en) * 1968-05-21 1972-07-04 Parke Davis & Co 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof
US4049495A (en) * 1974-06-07 1977-09-20 Sankyo Company Limited Physiologically active substances and fermentative process for producing the same
US4342767A (en) * 1980-01-23 1982-08-03 Merck & Co., Inc. Hypocholesteremic fermentation products
DK149080C (da) * 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3846541A (en) * 1970-10-15 1974-11-05 Pharmacia Ab Treatment of hypercholesteremia
EP0010299A1 (fr) * 1978-10-19 1980-04-30 Merck & Co. Inc. Composition pharmaceutique utilisable pour le traitement d'hypercholestérémie

Also Published As

Publication number Publication date
EP0276807A2 (fr) 1988-08-03
AU1422388A (en) 1988-08-10
KR890700343A (ko) 1989-04-24
DK536088A (da) 1988-09-27
WO1988005296A2 (fr) 1988-07-28
DK536088D0 (da) 1988-09-27
EP0276807A3 (fr) 1988-10-12

Similar Documents

Publication Publication Date Title
MX9203808A (es) Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
GR900300016T1 (en) A composition of matter for increasing intracellular atp levels and physical performance levels and for increasing the rate of wound repair
DE3767770D1 (en) Cholesterin-synthese-hemmer vom typ trans-6-(2-(3- oder 4-carboxamido-substituierte-pyrrol-1-yl)-alkyl)-4-hydroxypyran-2-on.
AU5786394A (en) Sulfonate and carbamate derivatives of 3-aroylbenzo(b)thiophenes
EP0433842A3 (en) 1,2,3-triazole derivatives active as inhibitors of the enzyme hmg-coa reductase and pharmaceutical compositions containing them
EP1452172A3 (fr) Préparation pharmaceutique composite.
AU583568B2 (en) Improved pharmaceutical composition containing 13-cis vitamin A acid as the active ingredient
EP0352864A3 (fr) Composés actifs comme inhibiteurs de la synthèse de cholestérol
FR2684876B1 (fr) Compositions pharmaceutiques stabilisees comprenant un compose inhibiteur de la hmg-coa reductase et procede pour leur preparation.
CA2233178A1 (fr) (methylsulfonyl)phenyl-2-(5h)-furanones en tant qu'inhibiteurs du cox-2
EP0852117A4 (fr) Amelioration du metabolisme lipidique
EP0773022A3 (fr) Composition pharmaceutique pour le traitement de la rhinite, contenant un sympathomimétique et du pantothenol et/ou l'acide pantothénique
WO1988005296A3 (fr) Compositions regulatrices de lipides
AU602769B2 (en) Lipid regulating compositions
EP0370481A3 (fr) Préparations pharmaceutiques pour une résorption augmentée de composés antibactériens
CA2248032A1 (fr) Agent abaissant le taux de cholesterol dans le serum
WO1998057620A3 (fr) Compositions, dispositifs, kits, et procede de modulation de la reponse immunitaire
AU3176695A (en) Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid
AU5544994A (en) Use of 17alpha-dihydroequilenin for lowering cholesterol
HUP0101354A2 (hu) E-2-[4-(4-klór-1,2-difenil-1-butenil)-fenoxi]-etanol észterei, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
AU644621B2 (en) Pharmaceutical composition for treating or preventing retroviral infections
WO1998001124A3 (fr) Preparation pharmaceutique contenant du nimesulide pour usage topique
CA2129527A1 (fr) Composition pharmaceutique utilisable comme analgesique contenant l'acide (benzoyl-3 phenyl)-2 propionique-(r)
CA2119777A1 (fr) Agent ameliorant le metabolisme des lipides sanguins
MX9302986A (es) Medicamento que contiene metrifonato y procedimiento para su preparacion

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AT AU BB BG BR CH DE DK FI GB HU JP KP KR LK LU MC MG MW NL NO RO SD SE SU US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE FR GB IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AT AU BB BG BR CH DE DK FI GB HU JP KP KR LK LU MC MG MW NL NO RO SD SE SU

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE FR GB IT LU NL SE

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642